Announcing a new article publication for Zoonoses journal. Methicillin resistant Staphylococcus aureus (MRSA) and Vancomycin ...

MRSA: Methicillin-resistant Staphylococcus aureus, a type of bacteria that is resistant to many antibiotics, making infections difficult to treat. Minimum Inhibitory Concentration (MIC): The ...

The rapid emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA ... that compare various antibiotics for the treatment of different types of infections.

Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus. Staphylococcus aureus is a leading cause of nosocomial and community acquired infections.

Staphylococcus aureus Bacteremia Market The dynamics of the Staphylococcus aureus Bacteremia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and ...

Researchers have described how the bacterium Staphylococcus aureus genetically adapts to humans, including mutations that allow some strains to evade the immune system and become resistant to ...

Shares of Savara Inc (NASDAQ:SVRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ...

The antibody from Chicago-based Immunartes is designed to neutralize the immune-evasive mechanisms of Staphylococcus aureus.

Antimicrobial Resistance Diagnostics market is growing rapidly due to the high prevalence of antimicrobial resistance and the critical need. VANCOUVER, BRI ...

including infections caused by methicillin-resistant Staphylococcus aureus (MRSA) Dalbavancin is under development for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections, ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...